AusPAR: Xpovio | Therapeutic Goods Administration (TGA)

AusPAR

AusPAR: Xpovio [PDF, 1.52 MB]

AusPAR: Xpovio [Word, 2.49 MB]

Attachment: Product information for Xpovio [PDF, 380.27 KB]

Attachment: Product information for Xpovio [Word, 195 KB]

Device/Product Name

Xpovio

Active ingredients

Selinexor

AusPAR Date

1 November 2022

Published

15 November 2022

Submission Number

PM-2020-05458-1-6

Submission Type

New chemical entity

Decision

Approved